Early-Stage Resectable or Locally Advanced Unresectable Non-Small Cell Lung Cancer research hub

C6461010 - An Interventional, Open-Label, Phase 2 Study to Investigate the Safety and Efficacy of PF-08634404 Monotherapy or in Combination in Adult Participants with Early-Stage Resectable or Locally Advanced Unresectable Non-Small Cell Lung Cancer

This study is testing a new cancer medicine called PF-08634404. Researchers want to see how safe and effective it is when given on its own or with standard chemotherapy for adults with non-small cell lung cancer, either before surgery or when surgery is not an option.